Art
J-GLOBAL ID:201902226977893774   Reference number:19A2028471

The Glucagon-Like Peptide-1 Receptor Agonist Exendin-4 Inhibits Lipopolysaccharide-Induced Osteoclast Formation and Bone Resorption via Inhibition of TNF-α Expression in Macrophages

グルカゴン様ペプチド-1受容体作動薬エキセンジン-4はマクロファージにおけるTNF-α発現の阻害を介してリポ多糖類誘導破骨細胞形成と骨吸収を阻害する【JST・京大機械翻訳】
Author (9):
Material:
Volume: 2018  Page: Null  Publication year: 2018 
JST Material Number: U7019A  ISSN: 2314-8861  Document type: Article
Article type: 原著論文  Country of issue: United Kingdom (GBR)  Language: ENGLISH (EN)
Abstract/Point:
Abstract/Point
Japanese summary of the article(about several hundred characters).
All summary is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
Glucagon-like peptide-1 (GLP-1...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A2028471&from=J-GLOBAL&jstjournalNo=U7019A") }}
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.

Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
, 【Automatic Indexing@JST】
JST classification (5):
JST classification
Category name(code) classified by JST.
Biophylaxis and immune systems in general  ,  Basic medicine on musculoskeletal system  ,  Physiology and pathogenicity of microbial infection  ,  Immunologic diseases,allergic diseases in general.  ,  Immunological reaction in general 
Reference (45):
  • A. Moayeri, M. Mohamadpour, S. F. Mousavi, E. Shirzadpour, S. Mohamadpour, M. Amraei, "Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis," Therapeutics and Clinical Risk Management, vol. Volume 13, pp. 455-468, 2017.
  • J. S. Walsh, T. Vilaca, "Obesity, type 2 diabetes and bone in adults," Calcified Tissue International, vol. 100, no. 5, pp. 528-535, 2017.
  • A. Montagnani, S. Gonnelli, "Antidiabetic therapy effects on bone metabolism and fracture risk," Diabetes, Obesity & Metabolism, vol. 15, no. 9, pp. 784-791, 2013.
  • M. T. Bazelier, A. M. Gallagher, T. P. van Staa, C. Cooper, H. G. Leufkens, P. Vestergaard, F. de Vries, "Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?," Pharmacoepidemiology & Drug Safety, vol. 21, no. 5, pp. 507-514, 2012.
  • M. T. Bazelier, P. Vestergaard, A. M. Gallagher, T. P. van Staa, C. Cooper, H. G. Leufkens, F. de Vries, "Risk of fracture with thiazolidinediones: disease or drugs?," Calcified Tissue International, vol. 90, no. 6, pp. 450-457, 2012.
more...

Return to Previous Page